GeneDx
(NASDAQ) WGS
GeneDx Financials at a Glance
Market Cap
$2.05B
Revenue (TTM)
$442.68M
Net Income (TTM)
-$77.81M
EPS (TTM)
-$2.67
P/E Ratio
-25.90
Dividend
$0.00
Beta (Volatility)
1.86 (High)
Dividend
$0.00
Beta (Volatility)
1.86 (High)
Price
$68.77
Volume
549,359.907
Open
$69.00
Price
$68.77
Volume
549,359.907
Open
$69.00
Previous Close
$69.12
Daily Range
$67.65 - $69.96
52-Week Range
$32.21 - $170.87
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.86 (High)
Price
$68.77
Volume
549,359.907
Open
$69.00
Previous Close
$69.12
Daily Range
$67.65 - $69.96
52-Week Range
$32.21 - $170.87
Estimated Earnings Date
Aug 4, 2026
WGS News
WGS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GeneDx
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
1,300
CEO
Katherine A. Stueland
Website
www.genedx.comHeadquarters
Stamford, CT 06902, US
WGS Financials
Key Financial Metrics (TTM)
Gross Margin
68.35%
Operating Margin
-7.72%
Net Income Margin
-17.58%
Return on Equity
-27.50%
Return on Capital
-2.56%
Return on Assets
-15.37%
Earnings Yield
-3.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.05B
Shares Outstanding
29.69M
Volume
549.36K
Avg. Volume
1.32M
Financials (TTM)
Gross Profit
$302.56M
Operating Income
-$34.19M
EBITDA
-$48.50M
Operating Cash Flow
-$9.31M
Capital Expenditure
-$19.34M
Free Cash Flow
-$28.65M
Cash & ST Invst.
$170.69M
Total Debt
$168.19M
GeneDx Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$102.25M
+17.4%
Gross Profit
$68.21M
+16.6%
Gross Margin
66.71%
N/A
Market Cap
$2.05B
N/A
Market Cap/Employee
$2.05M
N/A
Employees
1,000
N/A
Net Income
-$63.32M
-869.8%
EBITDA
-$54.89M
-23359.7%
Quarterly Fundamentals
Total Cash
$170.69M
+7.2%
Total Debt
$168.19M
+46.5%
Accounts Receivable
$76.93M
+67.0%
Inventory
$12.24M
-3.3%
Long Term Debt
$163.06M
+46.0%
Short Term Debt
$5.13M
+64.2%
Return on Assets
-15.37%
N/A
Return on Invested Capital
-8.17%
N/A
Free Cash Flow
-$38.86M
-1058.8%
Operating Cash Flow
-$32.41M
-418.3%